References 1 Smith AD, Refsum H
The findings cited above are taken from preclinical, animal-model, and in vitro studies and are reported here for research context only
Study Finds Diabetes Medication Reduces Risk Of Death And Heart Disease In People With Arthritis August 12, 2024 (Vancouver) A study conducted by Arthritis Research Canada has revealed that certain diabetes medications, specifically glucagon-like peptide-1 receptor agonists (GLP-1-RAs) like semaglutide (Ozempic), reduced the risk of death and heart attacks in people with immune-mediated inflammatory diseases (IMIDs), such as rheumatoid arthritis, psoriasis, and lupus, who also have type 2 diabetes
As someone familiar with ingredient sourcing challenges, I recognize how valuable it can be for a manufacturer to maintain strong relationships with local suppliers of botanical ingredients, because this often leads to greater traceability and consistency in raw material quality